BDBM312473 2-[3-(3-Cyclopropyl-[1,2,4]oxadiazol-5-yl)-6,7-dihydro-4H-thieno[3,2-c]pyran-2-ylcarbamoyl]-cyclopent-1-enecarboxylic acid::US9604977, Example 219

SMILES: OC(=O)C1=C(CCC1)C(=O)Nc1sc2CCOCc2c1-c1nc(no1)C1CC1

InChI Key: InChIKey=PXOCPISXWQUKDR-UHFFFAOYSA-N

Data: 2 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 312473   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Fatty acid-binding protein 5 (FABP5) (Homo sapiens (Human))	BDBM312473 (2-[3-(3-Cyclopropyl-[1,2,4]oxadiazol-5-yl)-6,7-dih...) Show SMILES OC(=O)C1=C(CCC1)C(=O)Nc1sc2CCOCc2c1-c1nc(no1)C1CC1 |t:3| Show InChI InChI=1S/C19H19N3O5S/c23-16(10-2-1-3-11(10)19(24)25)21-18-14(12-8-26-7-6-13(12)28-18)17-20-15(22-27-17)9-4-5-9/h9H,1-8H2,(H,21,23)(H,24,25)	PDB UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	57	n/a	n/a	n/a	n/a	n/a	n/a
Hoffman-La Roche Inc. US Patent					Assay Description Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra...				US Patent US9604977 (2017) BindingDB Entry DOI: 10.7270/Q2FX7CJB
					More data for this Ligand-Target Pair
Fatty acid-binding protein 4 (FABP4) (Homo sapiens (Human))	BDBM312473 (2-[3-(3-Cyclopropyl-[1,2,4]oxadiazol-5-yl)-6,7-dih...) Show SMILES OC(=O)C1=C(CCC1)C(=O)Nc1sc2CCOCc2c1-c1nc(no1)C1CC1 |t:3| Show InChI InChI=1S/C19H19N3O5S/c23-16(10-2-1-3-11(10)19(24)25)21-18-14(12-8-26-7-6-13(12)28-18)17-20-15(22-27-17)9-4-5-9/h9H,1-8H2,(H,21,23)(H,24,25)	PDB UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	18	n/a	n/a	n/a	n/a	n/a	n/a
Hoffman-La Roche Inc. US Patent					Assay Description Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra...				US Patent US9604977 (2017) BindingDB Entry DOI: 10.7270/Q2FX7CJB
					More data for this Ligand-Target Pair